CFTR modulator therapies have transformed CF care, but lung infections remain a challenge
Changes in symptoms and reduced sputum availability are creating new needs for diagnostics that can detect infection and pulmonary exacerbations, guide treatment decisions, and monitor treatment response.
Join the CF AMR Syndicate at a free developer event in Stockholm on Friday 9 April 2027, ahead of the main ESCMID Global conference programme, to explore how your technology could contribute.
